Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer-Reference-Cited by-同舟云学术

Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer

Published:2017-10-12 Issue:12 Volume:7 Page:1420-1435
ISSN:2159-8274
Container-title:Cancer Discovery
language:en
Short-container-title:Cancer Discov

Author:

Gettinger Scott,Choi Jungmin,Hastings Katherine,Truini Anna,Datar Ila,Sowell Ryan,Wurtz Anna,Dong Weilai,Cai Guoping,Melnick Mary Ann,Du Victor Y.,Schlessinger Joseph,Goldberg Sarah B.,Chiang Anne,Sanmamed Miguel F.,Melero Ignacio,Agorreta Jackeline,Montuenga Luis M.,Lifton Richard,Ferrone Soldano,Kavathas Paula,Rimm David L.,Kaech Susan M.,Schalper Kurt,Herbst Roy S.,Politi Katerina

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology

Cited by 537 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunological hide-and-seek: epigenetically reprogrammed cancer cells and the dynamics of CD8+ T cells;Molecular Biology Reports;2024-09-04

2. Predictive value and molecular correlates of MYC immunohistochemistry and copy number gain in non-small cell lung carcinomas treated with immunotherapy;Lung Cancer;2024-09

3. Tumor antigen presentation and the associated signal transduction during carcinogenesis;Pathology - Research and Practice;2024-09

4. IL-2-armored peptide-major histocompatibility class I bispecific antibodies redirect antiviral effector memory CD8+ T cells to induce potent anti-cancer cytotoxic activity with limited cytokine release;mAbs;2024-08-28

5. Overcoming Resistance to Checkpoint Inhibitors with Combination Strategies in the Treatment of Non-Small Cell Lung Cancer;Cancers;2024-08-22